Enovis Corporation — Cyborg Score 4/10

Mixed
Orthopedic Medical Devices & Rehabilitation Technology

Strategic Profile

After a major spin-off in April 2022 that separated its industrial ESAB business, the company completed its transformation into a pure-play medical technology company. In September 2023, Enovis announced a definitive agreement to acquire LimaCorporate for approximately €800 million, which strengthens its reconstructive orthopedics portfolio. The company operates through two segments: Prevention and Recovery (consumer-focused products) and Reconstructive (surgical solutions).

Cyborg Score Rationale

The company generated $2.25B in trailing twelve-month revenue, demonstrating solid market presence. However, the company reported negative EPS of -$20.75 for the twelve-month period, indicating significant profitability challenges. The market cap of approximately $1.46B suggests modest valuation relative to its revenue base.

Top Insights

  • Pure-play orthopedic focus achieved through strategic spin-off and divestments, with enhanced portfolio through LimaCorporate acquisition
  • Dual segment strategy balances high-volume prevention/recovery products with higher-margin reconstructive surgical solutions
  • Significant profitability challenges despite revenue growth suggest integration costs or operational inefficiencies requiring attention
  • Strong brand portfolio including DonJoy, Aircast, Chattanooga, and Procare providing diversified market reach

Named Competitors

  • Orthopedic Reconstruction & Joint Replacement — Leading global orthopedic medical device manufacturer
  • Orthopedic Devices & Surgical Solutions — Diversified medical technology company with major orthopedic portfolio
  • Joint Replacement & Orthopedic Systems — Diversified healthcare conglomerate with orthopedic surgical business

Recent Developments

  • (September 2023) Acquisition of LimaCorporate for €800 million to expand reconstructive joint products
  • (January 2026) Oliver Engert appointed Chief Administrative Officer
  • (February 2026) 2025 full-year financial results announcement with fourth quarter performance review

Open the full interactive Enovis Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →